P

Inventor

HUMPHREYS DAVID PAUL

GB46 patents
⚠️ This page may combine multiple inventors who share the name “HUMPHREYS DAVID PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UCB PHARMA SA

19 patents
US9309327B2Apr 12, 2016

Dual specificity antibody fusions

UCB PHARMA SA32 citations96
US9040048B2May 26, 2015

Antibody molecules having specificity for human OX40

UCB PHARMA SA19 citations92
US9550973B2Jan 24, 2017

Bacterial host strain

UCB PHARMA SA5 citations84
US9315770B2Apr 19, 2016

Bacterial host strain

UCB PHARMA SA11 citations84
US8053562B2Nov 8, 2011

Modified antibody fragments

UCB PHARMA SA13 citations84
US10100130B2Oct 16, 2018

Dual specificity antibody fusions

UCB PHARMA SA5 citations83
US9828438B2Nov 28, 2017

Dual specificity antibody fusions

UCB PHARMA SA7 citations83
US9587227B2Mar 7, 2017

Bacterial host strain comprising a mutant spr gene and having reduced Tsp activity

UCB PHARMA SA2 citations73
US9493559B2Nov 15, 2016

Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity

UCB PHARMA SA5 citations73
US9493558B2Nov 15, 2016

Bacterial host strain comprising a mutant SPR gene and a wild-type TSP gene

UCB PHARMA SA5 citations73
US10421816B2Sep 24, 2019

Multivalent antibodies

UCB PHARMA SA2 citations72
US9902768B2Feb 27, 2018

Sequence asymmetric modified IgG4 bispecific antibodies

UCB PHARMA SA5 citations71
US9951365B2Apr 24, 2018

Recombinant bacterial host cell for protein expression

UCB PHARMA SA4 citations68
US7989594B2Aug 2, 2011

Modified antibody fab fragments

UCB PHARMA SA5 citations63
US11427650B2Aug 30, 2022

Dual specificity antibody fusions

UCB PHARMA SA0 citations61
US12091450B2Sep 17, 2024

Antibodies of the class IGG4

UCB PHARMA SA0 citations59
US10759844B2Sep 1, 2020

Disulfide stabilised antibodies and fragments thereof

UCB PHARMA SA0 citations52
US9957328B2May 1, 2018

Bacterial host strain expressing recombinant DSBC

UCB PHARMA SA1 citations52
US7662609B2Feb 16, 2010

E.coli host cells with modified PhoS/PstS periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs

UCB PHARMA SA1 citations50

UCB BIOPHARMA SPRL

8 patents

ELLIS MARK

5 patents

HUMPHREYS DAVID PAUL

5 patents

UCB Biopharma SRL

5 patents

CELLTECH THERAPEUTICS LTD

1 patent

BAKER TERENCE S

1 patent

HEYWOOD SAM PHILIP

1 patent

CELLTECH R&D LTD

1 patent